Activist Group Radoff and Torok Increase Stake to 7.6%, Challenges Board's "Poison Pill"

summarizeSummary

Activist investors Bradley L. Radoff and Michael Torok have increased their stake in Seer, Inc. to 7.6% and are openly criticizing the Board's recent adoption of a "poison pill" as an entrenchment tactic.

check_boxKey Events

• Activist Stake Increased to 7.6%

  The Radoff and Torok activist group has increased its aggregate beneficial ownership in Seer, Inc. from 6.5% to 7.6% of outstanding shares, now holding 4,277,528 shares.

• Direct Challenge to Poison Pill

  The activist group explicitly states its "deep concern" over the Board's adoption of the Tax Benefit Preservation Plan (NOL Pill) on February 26, 2026, calling it an "entrenchment device" designed to deter a proxy contest. They demand evidence justifying the pill.

• Recent Share Purchases

  Bradley L. Radoff purchased 510,232 shares between February 20 and February 26, 2026, and JEC II Associates, LLC purchased 117,296 shares on February 26, 2026.

• Historical Governance Concerns Cited

  The filing references the Board's prior attempt to delay the conversion of high-vote Class B common stock, suggesting a pattern of actions perceived as anti-shareholder.

auto_awesomeAnalysis

This amended Schedule 13D reveals a significant escalation in the activist campaign by Bradley L. Radoff and Michael Torok. The group has increased its aggregate beneficial ownership to 7.6% and is directly challenging the Board's recent adoption of a Tax Benefit Preservation Plan (poison pill), which they view as an entrenchment device. This sets the stage for a potential proxy contest and indicates a deepening conflict between the activist shareholders and the company's current leadership, raising questions about corporate governance and strategic direction. This follows the initial 13D filing on February 20, 2026, and the company's adoption of the poison pill on February 27, 2026.